Wyoming MPJE (Pharmacy Jurisprudence) Practice Exam 2026 - Free MPJE Practice Questions and Study Guide

Phase 3 clinical trials focus on gathering data regarding both the safety and efficacy of the drug being studied in a very large population. These trials are crucial in providing comprehensive information on how well the drug works and its safety profile before it can be considered for approval by regulatory agencies such as the FDA. Option D is the correct answer because it accurately reflects the primary goal of Phase 3 clinical trials.

Options A, B, and C are not the focus of Phase 3 clinical trials. Option A mentioning cost-effectiveness and the general public is more related to health economics and market access considerations. Option B focusing on efficacy in a small population is more characteristic of early-phase clinical trials, particularly Phase 1 and Phase 2. Option C emphasizing long-term safety in a small population with the disease is important but typically addressed in post-marketing surveillance studies rather than Phase 3 clinical trials.